Electrophoretic Characterizations of Cross-Linked Fibrinogen Derivatives in Blood and Vascular Tissue by Zonal Immobilization on Glyoxyl Agarose

  • John R. Shainoff
  • Rafael Valenzuela
  • Robert Graor
  • David A. Urbanic
  • Patricia M. DiBello
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 281)


Current definitions of fibrinogen derivatives produced in course of clot formation and lysis derive from electrophoretic and immunochemical analyses of the alterations that the purified protein undergoes during these reactions (1, 2). Methods for profiling the distribution of fibrinogen-derivatives in blood continue to improve as new methods arise for immunoprobing electrophoregrams. Polyacrylamide gel electrophoregrams (PAGE) are too impermeable to be probed directly with antibody. The earliest profiles of molecular weight distributions of the fibrinogen-related antigens in blood used immunosorbents for specific absorption of the protein from blood, followed by electrophoretic analysis of desorbed protein (3). Western-blotting (4) in which proteins are electro-transferred out of the electrophoregram to produce a replica on cellulose nitrate or other adsorptive membrane is now commonly used for immunoprobing. However, as might be anticipated (5), this technique does not work well with fibrinogen; it and its polymers do not transfer well due to their precipitation when separated from SDS. Because of relatively poor transfer of the intact protein, blots made of fibrinogen-related antigens usually show the degraded and readily transferred forms at levels far out of proportion to their actual concentrations in the samples. To eliminate the uncertainties that arise from transfer procedures, we have devised methods for directly immunoprobing the electrophoregrams. The present communication outlines underlying principles of the methodology, and surveys some of the findings regarding the composition of fibrinogen which were discovered with it.


Aortic Intima Zonal Immobilization Early Profile Glyoxyl Agarose Neutral Phosphate Buffer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    M. L. Schwartz S. V. Pizzo, R. L. Hill, and P. A. McKee, Human factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin, J. Biol. Chem., 248:1395 (1973).PubMedGoogle Scholar
  2. 2.
    V. J. Marder, R. N. Shulman, and W. R. Carroll, High molecular weight derivatives of human fibrinogen produced by plasmin, J. Biol. Chem.,244:2111 (1969).PubMedGoogle Scholar
  3. 3.
    H. Graeff and R. Hafter, Detection and relevance of cross-linked fibrin derivatives in blood, Sem. in Thromb. & Hemost., 8:57 (1982).CrossRefGoogle Scholar
  4. 4.
    H. Towbin, T. Taehelin, and J. Gordon, Electrotransfer of proteins from polyacrylamide gels to nitrocellulose sheets, Proc. Natl. Acad. Sci. USA, 76:4350 (1979).PubMedCrossRefGoogle Scholar
  5. 5.
    W. Lin and H. Kasamatsu, On the electrotransfer of polypeptides from gels to nitrocellulose membranes, Anal. Biochem., 128:302 (1983).PubMedCrossRefGoogle Scholar
  6. 6.
    J. R. Shainoff, Zonal immobilization of proteins, Biochem. Biophys. Res. Commun., 95:690 (1980).PubMedCrossRefGoogle Scholar
  7. 7.
    J. R. Shainoff and B. N. Dardik, Cascade immunoelectrophoresis: combined electrophoretic and solid-phase processing of immunoreactive protein by zonal immobilization, J. Immunol. Methods 42:229 (1981).PubMedCrossRefGoogle Scholar
  8. 8.
    J. R. Shainoff, Zonal Immobilization of Proteins and Peptides, Guidelines for Electrophoretic, Chromatographic, and Dot-Blot Analyses on Glyoxyl Agarose and Composite Gels. (Manuscript submitted) (1989).Google Scholar
  9. 9.
    R. F. Borch, M. D. Berstein, and H. D. Durst, The cyanohydridoborate anion as a selective reducing agent, J. Am. Chem. Soc., 93:2897 (1971).CrossRefGoogle Scholar
  10. 10.
    A. C. Peacock and C. W. Dingman, Molecular weight estimation and separation of ribonucleic acid by electrophoresis in agarose-acrylamide composite gels, Biochemistry, 7:668 (1968).PubMedCrossRefGoogle Scholar
  11. 11.
    P. B. H. O’Connell and C. J. Brady, Polyacrylamide gels with modified cross-linkages, Anal. Biochem., 76:63 (1976).PubMedCrossRefGoogle Scholar
  12. 12.
    J. S. Finlayson and M. W. Mosesson, Heterogeneity of human fibrinogen, Biochemistry, 2:42 (1963).CrossRefGoogle Scholar
  13. 13.
    A. Henschen and P. Edman, Large scale preparation of S-carboxymethylated chains of human fibrin and fibrinogen and the occurrence of y-chain variants, Biochim. Biophys. Acta,263:351 (1972).PubMedCrossRefGoogle Scholar
  14. 14.
    J. R. Shainoff, R. Valenzuela, S. R. Gonda, and M. Caulfield, Blot-screening of culture fluid immunoreactivities on glyoxyl agarose films, Biotechniques, 4:120 (1986).Google Scholar
  15. 15.
    D. M. Boorsma, Preparation of HRP-labelled antibodies, In: A. C. Cuello, ed. Immunohistochemistry, NY: John Wiley & Sons, 87, (1983).Google Scholar
  16. 16.
    J. M. Coll, Heme increases peroxidase-antibody activity in aged conjugates, J. Immunol. Methods,104:259 (1987).PubMedCrossRefGoogle Scholar
  17. 17.
    B. D. Hames and D. Rickwood, Gel Electrophoresis of Proteins, Oxford: IRL Press (1981).Google Scholar
  18. 18.
    R. Valenzuela R. J. R. Shainoff, F. V. Lucas, B. J. Kudryk, and J. M. Anderson, Polypeptide-chain composition of fibrinogen oligomers in the human aortic intima and blood plasma. In: M. W. Mosesson et al. eds. Fibrinogen 3. Biochemistry, Biological Functions, Gene Regulation and Expression. Amsterdam: Excerpta Medica, 313 (1988).Google Scholar
  19. 19.
    P. A. McKee, M. L. Schwartz, S. V. Pizzo, and R. L. Hill, Cross-linking of fibrin by fibrin-stabilizing factor, Ann. NY Acad. Sci., 202:128 (1972).CrossRefGoogle Scholar
  20. 20.
    E. B. Smith, G. A. Keen, and A. Grant, Origin of fibrin/fibrinogen degradation products in atherosclerotic lesions, in: M. W. Mosesson, D. L. Amrani, K. R. Siebenblist, J. P. Diorio, eds. Fibrinogen 3: Biochemistry, Biological Functions, Gene Regulation and Expression. Amsterdam: Excerpta Medica, 317 (1988).Google Scholar
  21. 21.
    E. B. Smith, Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosisClinics in Haematology, 15:355 (1986).PubMedGoogle Scholar
  22. 22.
    V. Kao and R. W. Wissler, A study of the immunohistochemical localization of serum lipoproteins and other plasma proteins in human atherosclerotic lesions, Exper. Molec. Path., 4:465 (1965).CrossRefGoogle Scholar
  23. 23.
    J. R. Shainoff and I. H. Page, Deposition of modified fibrinogen within the aortic intima, Atherosclerosis, 16:287 (1972).PubMedCrossRefGoogle Scholar
  24. 24.
    A. Bini, J. Jr. Fenoglio, J. Sobel, J. Owen, M. Fejgl, and K. L. Kaplan, Immunochemical characterization of fibrinogen, fibrin I, and fibrin II in human thrombi and atherosclerotic lesions, Blood, 69:1038 (1987).PubMedGoogle Scholar
  25. 25.
    S. I. Chung, Comparative studies on tissue transglutaminase and factor XIII, Ann. NY Acad. Sci., 202:240 (1972).PubMedCrossRefGoogle Scholar
  26. 26.
    H. Kanaide and J. R. Shainoff, Cross-linking of fibrinogen and fibrin by fibrin-stabilizing factor, J. Lab. Clin. Med., 86:574 (1975).Google Scholar
  27. 27.
    M. W. Mosesson, K. R. Siebenblist, D. L. Amrani, and J. P. Diorio, Identification of covalently linked trimeric and tetrameric D domains in crosslinked fibrin, Proc. Natl. Acad. Sci. USA, 86:1113 (1989).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1990

Authors and Affiliations

  • John R. Shainoff
    • 1
  • Rafael Valenzuela
    • 1
  • Robert Graor
    • 1
  • David A. Urbanic
    • 1
  • Patricia M. DiBello
    • 1
  1. 1.Research Institute of the Cleveland Clinic FoundationClevelandUSA

Personalised recommendations